Vericel Corp Ord
Biotechnology
Healthcare
VCEL
49.09 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
38.09
52 week high
61.80
high
44.60
52 week low
38.60
low
37.83
growth
-7.25 %
previous Close
38.60
P/E ratio
market cap
2.83 B
div yield
0
usd
Sep 2024
qoq
revenue
57.91 M
9.96 %
net incoming
-901.00 K
80.76 %
eps
0.00 %
80.00 %
eps surprise
60.00 %
net profit margin
-1.56 %
7.00 %
operating incoming
-2.47 M
59.13 %
net change in cash
-5.50 M
-207.67 %
cash on hand
53.68 M
-29.23 %
cost of revenue
16.25 M
1.19 %
top top